tradmap

IVZ Financials Invesco

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 0.7% per year over the past 5 years.
  • Operating margin has contracted, at -10.9% in the latest year.
  • Free cash flow has grown 5.3% per year over the past 5 years.

Financial health

  • Total debt ($1.8B) exceeds cash ($1.0B); net debt is $788M.
  • Total debt has grown slower than revenue (-2.6% vs 0.7% per year).
  • Operating income covered interest expense -8.4× in the latest year.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 26.2% of free cash flow.
  • The dividend has grown 1.1% per year over the past 5 years.
Revenue & net income
-$175M $3B $7B $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-11% 9% 29% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $721M $1B 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $1B $2B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$3B -$679M $2B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $6.4B -$175M 0.0% -10.9% $1.4B $1.8B $1.0B
2024 $6.1B $752M 0.0% 13.7% $1.1B $891M $987M
2023 $5.7B -$168M 0.0% -7.6% $1.1B $1.5B $1.5B
2022 $6.0B $926M 0.0% 21.8% $510M $1.5B $1.2B
2021 $6.9B $2.0B 0.0% 25.9% $969M $2.1B $1.9B
2020 $6.1B $808M 0.0% 15.0% $1.1B $2.1B $1.4B
2019 $6.1B $738M 0.0% 13.2% $992M $2.1B $1.0B
2018 $5.3B $883M 0.0% 22.7% $726M $2.4B $1.1B
2017 $5.2B $1.2B 0.0% 24.8% $1.0B $2.1B $2.0B
2016 $4.7B $868M 0.0% 24.3% $506M $2.1B $1.3B
2015 $964M $1.0B $2.1B $1.9B
2014 $1.0B $1.1B $1.6B $1.5B
2013 $983M $692M $1.6B $1.3B
2012 $587M $720M $1.2B $836M
2011 $622M $858M $1.3B $727M

Valuation over time

How the market has priced IVZ against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 7.2 14.4 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 1.0 2.0 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 3.0 6.0 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is IVZ growing its revenue and profit?

Over the past 5 years, Invesco's revenue has grown 0.7% per year. These are computed facts, not advice.

How much debt does IVZ have?

As of FY2025, Invesco reported $1.8B of total debt against $1.0B of cash; operating income covered interest expense -8.4×.

What is IVZ's profit margin?

In FY2025, gross margin was —, operating margin -10.9%, and net margin -2.7%.

What is IVZ's P/E ratio?

As of Jun '26, Invesco traded at a price-to-earnings ratio of about 14.4× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.